NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/07/2023
Back to search
Official data from USPTO
NNE PHARMAPLAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079054097Class
35, 36, 37, 41, 42
Filing
79054097
Registration
3767521
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
01/07/2023
Trademark type
Combined
Nice classes
35, 36, 37, 41, 42
Filing date
01/09/2008
Registration date
03/30/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
02/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
DK
Examiner
HABEEB, MYRIAH A
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NNE A/S
NNE Pharmaplan A/S
Representatives
Claudia A. Smith White & Case LLP
Technical classification
Nice Classes
Class 35Class 36Class 37Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management consultancy as well as development of processes for the analysis and implementation of strategy plans and management projects in the pharmaceutical and biotechnical industries including for healthcare and for hospitals
Class 36
Financial consultations in the fields of planning and producing and construction of medical and biotechnical installations; financial servicesrisk evaluationsfinancial risk management
Class 37
Construction activitiesconstruction of medical and biotechnical installationsresearch laboratories and hospitals
Class 41
Providing educational training courses in the field of goods manufacturing practices for the production of pharmaceutical and biotechnical products
Class 42
Engineering consultancyconsultancy in architecture and environmental planningincluding consultancy in the planning of pharmaceutical and biotechnical industriesrelated industries and hospitals; engineering services in the fields of plant engineeringventilationheating and technical engineering all in the pharmaceutical and biotechnological field
Publications
History of USPTO decisions and trademark events.
50 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/09/2022
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/16/2021
INPC
INVALIDATION PROCESSED
12/16/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/30/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/18/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/25/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/27/2017
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/02/2016
71AG
REGISTERED-SEC.71 ACCEPTED
05/02/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/18/2016
ES71
TEAS SECTION 71 RECEIVED
02/26/2016
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/22/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/15/2010
FIMP
FINAL DISPOSITION PROCESSED
07/15/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2010
PUBO
PUBLISHED FOR OPPOSITION
01/12/2010
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/07/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2009
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2009
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/26/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/16/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/16/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/16/2009
CNFR
FINAL REFUSAL MAILED
08/20/2009
CNFR
FINAL REFUSAL WRITTEN
08/19/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
07/31/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/31/2009
PAPER RECEIVED
07/28/2009
CNRT
NON-FINAL ACTION MAILED
02/03/2009
CNRT
NON-FINAL ACTION WRITTEN
02/02/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2009
ALIE
ASSIGNED TO LIE
01/07/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2008
RFNT
REFUSAL PROCESSED BY IB
07/25/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/03/2008
RFRR
REFUSAL PROCESSED BY MPU
07/03/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/03/2008
CNRT
NON-FINAL ACTION WRITTEN
07/02/2008
DOCK
ASSIGNED TO EXAMINER
06/27/2008
NWAP
NEW APPLICATION ENTERED
06/27/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/26/2008
Continuous trademark protection
Get notified about every new filing that threatens NNE PHARMAPLAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.